title: Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion.
authors.affiliation: Dermik Laboratories, Inc., Collegeville, Pennsylvania 19426, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Packman
authors.forename: R H
authors.initials: RH
authors.lastname: Brown
authors.forename: F E
authors.initials: FE
authors.lastname: Dunlap
authors.forename: S J
authors.initials: SJ
authors.lastname: Kraus
authors.forename: G F
authors.initials: GF
authors.lastname: Webster
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000287:Administration, Topical; D000328:Adult; D000704:Analysis of Variance; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001585:Benzoyl Peroxide / Q000008:administration & dosage / Q000627:therapeutic use*; D002981:Clindamycin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D007641:Keratolytic Agents; D002981:Clindamycin; D004917:Erythromycin; C007084:clindamycin phosphate; D001585:Benzoyl Peroxide